- Volume is elevated versus the 13-week average, confirming attention.
VIKASLIFE
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Vikas Lifecare Limited · Consumer Defensive · Farm Products
Latest close
1.26 INR
-1.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -14.6% below the Trend Line and sits at 15.9% of its 52-week range. The latest completed week returned -1.6%, after a -9.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 48/100.
Setup score
23
out of 100
Latest Close
1.26 INR
7 Aug 2026
1W Return
-1.6%
latest completed week
4W Return
-9.4%
short-term follow-through
12W Return
-16.6%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
1.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.6%
Latest completed week; four-week move -9.4%.
Indicator stack
0/26
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 34.66%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
48/100
20 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -14.6% below the Trend Line and sits at 15.9% of its 52-week range. The latest completed week returned -1.6%, after a -9.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.19
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -9.4% over four weeks, -16.6% over 12 weeks, and -43.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.48Latest activity-pressure read.
Pressure change-191.3%Four-week change in activity pressure.
Leadership-25.93Latest relative-leadership reading.
RS change-24.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 79%
Model confidence 74%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength56/100Blend of value, momentum, and quality. Underlying universe rank 45; rank 1 is best.
Value92/100Relative valuation strength. Underlying universe rank 9; rank 1 is best.
Quality20/100Profitability and accounting quality. Underlying universe rank 81; rank 1 is best.
Momentum5/100Medium-term price momentum. Underlying universe rank 96; rank 1 is best.
Growth28/100Revenue and earnings growth. Underlying universe rank 73; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.4x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 90.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 3.0% Gross profit retained from each unit of revenue.
- Operating margin
- -11.0% Operating profit retained from revenue.
- Free-cash-flow margin
- 57.3% Free cash flow generated from revenue.
- Return on invested capital
- -6.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 4.0% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -0.1% Net share repurchases relative to market value.
- Shareholder yield
- -0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -1.3x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 20 relevant articles.
0 positive · 19 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-46.8%Distance below the 52-week high.
13-week volatility2.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher6 of 2619 weeks finished lower.
Best week+27.3%Week of 10 Apr.
Worst week-10.2%Week of 27 Mar.
Latest week-1.6%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains3
Flat weeks1
Modest losses11
Sharp losses8
Recent vol2.8%13-week weekly-return volatility.
Base vol5.5%52-week weekly-return volatility.
Up/down split15/36Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Consumer Defensive
4-week rank- / 100
Group average-0.4%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD51.0%positive activity pressure
RS44.0%positive relative leadership
Four-week leaders
IndustryIN Farm Products
4-week rank19 / 21
Group average-1.0%
Trend breadth23.8%
Trend23.8%active weekly trend signals
MD38.1%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape21/100
Trend, activity pressure, participation, and risk combine to a 21/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 34.66%Next-week expectancy is negative with a 34.66% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors43/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 86; Buyback Yield rank 75; Small Cap Core rank 23 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 20 relevant articles.
Solid Earnings Reflect Vikas Lifecare's (NSE:VIKASLIFE) Strength As A Business Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.26 INR | -1.6% | 1.48 INR | 3.54 INR | -0.48 | -25.93 | 12.1M | Off |
| 31 Jul 2026 | 1.28 INR | -2.3% | 1.49 INR | 3.56 INR | -0.23 | -25.01 | 10.4M | Off |
| 24 Jul 2026 | 1.31 INR | -2.2% | 1.51 INR | 3.57 INR | 0.07 | -22.21 | 8.9M | Off |
| 17 Jul 2026 | 1.34 INR | -3.6% | 1.53 INR | 3.58 INR | 0.34 | -23.17 | 13.7M | Off |
| 10 Jul 2026 | 1.39 INR | -4.1% | 1.55 INR | 3.59 INR | 0.53 | -20.88 | 8.8M | Off |
| 3 Jul 2026 | 1.45 INR | -0.7% | 1.56 INR | 3.60 INR | 0.54 | -18.60 | 2.7M | Off |
| 26 Jun 2026 | 1.46 INR | -1.4% | 1.57 INR | 3.61 INR | 0.53 | -18.21 | 0 | Off |
| 19 Jun 2026 | 1.48 INR | 2.1% | 1.59 INR | 3.62 INR | 0.58 | -17.80 | 1.7M | Off |
| 12 Jun 2026 | 1.45 INR | -2.0% | 1.60 INR | 3.63 INR | 0.57 | -18.95 | 1.5M | Off |
| 5 Jun 2026 | 1.48 INR | -2.6% | 1.62 INR | 3.64 INR | 0.61 | -17.29 | 1.2M | Off |
| 29 May 2026 | 1.52 INR | 5.6% | 1.64 INR | 3.65 INR | 0.68 | -16.51 | 10.5M | Off |
| 22 May 2026 | 1.44 INR | -4.6% | 1.65 INR | 3.66 INR | 0.69 | -22.45 | 7.8M | Off |
| 15 May 2026 | 1.51 INR | -5.6% | 1.68 INR | 3.67 INR | 0.76 | -19.38 | 5.4M | Off |
| 8 May 2026 | 1.60 INR | 1.9% | 1.70 INR | 3.68 INR | 0.83 | -17.39 | 4.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.